StockSelector.com
  Research, Select, & Monitor Friday, April 20, 2018 12:21:24 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Sorrento Therapeutics, Inc.$6.45$.254.03%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Sorrento Therapeutics, Inc. has an overall rank of 382 out of 6821 stocks based on 11 positive rankings and 3 negative rankings.

Positive Rankings
Historic Revenue Growth
Sorrento Therapeutics rank is 15
90 Day Gain
Sorrento Therapeutics rank is 65
Low vPut/Call
Sorrento Therapeutics has a low Put/Call ratio of 0.05 on active options expiring within the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sorrento Therapeutics is ranked 116.
10 Day Gain
Sorrento Therapeutics rank is 306
PEGValue
Sorrento Therapeutics has a PEG Value of $9.76. A stock is commonly considered to be fairly valued when its PE ratio equals its earnings growth rate. The PEG Value is the price where the PE Ratio, based on next year's earnings estimate, divided by the estimated growth rate over the next couple of years equals 1. This implies that if the company maintains its estimated growth rate, that the stock should gain 57.35% in the next year. Among companies with a PEG Value above the current stock price, Sorrento Therapeutics is ranked 365.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Sorrento Therapeutics is ranked 497.
Low Put/Call
Sorrento Therapeutics has a low Put/Call ratio of 0.28 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Sorrento Therapeutics is ranked 759.
Debt-to-Equity
Sorrento Therapeutics rank is 2032
Highest ROA
Sorrento Therapeutics rank is 2163
Highest Net Margin
Sorrento Therapeutics rank is 2187
Highest ROE
Sorrento Therapeutics rank is 2566
Negative Rankings
Negative Stoch Cross
Sorrento Therapeutics rank is 152
Price-to-Sales
Sorrento Therapeutics rank is 1685
Price-to-Book
Sorrento Therapeutics rank is 1960







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.